Literature DB >> 324483

Increased spontaneous activity of antibody-forming cells in the peripheral blood of patients with active SLE.

D R Budman, E B Merchant, A D Steinberg, B Doft, M E Gershwin, E Lizzio, J P Reeves.   

Abstract

Thirty-seven patients with criteria for systemic lupus erythematosus (SLE) and 18 normal controls were studied for their spontaneous background IgM antibody plaque-forming clell number to specific chemical haptens. Active SLE patients had significantly more plaque-forming cells in their peripheral blood to a total of five chemical determinants than did patients with inactive disease or controls. This increased number of plaque forming-cells correlated with depressed serum C3 levels by Spearman rank-order analysis. The finding of elevated numberof spontaneous IgM plaque-forming cells to defined chemical haptens supports the concept that active SLE demonstrates a generalized increase in B-cell activity toward a variety of antigens.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 324483     DOI: 10.1002/art.1780200312

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  55 in total

1.  Urine free light chains in SLE: clonal markers of B-cell activity and potential link to in vivo secreted Ig.

Authors:  J E Hopper; J Golbus; C Meyer; G A Ferrer
Journal:  J Clin Immunol       Date:  2000-03       Impact factor: 8.317

Review 2.  Genetic dissection of lupus nephritis in murine models of SLE.

Authors:  E K Wakeland; L Morel; C Mohan; M Yui
Journal:  J Clin Immunol       Date:  1997-07       Impact factor: 8.317

3.  B lymphocyte activation in systemic lupus erythematosus: spontaneous production of IgG antibodies to DNA and environmental antigens in cultures of blood mononuclear cells.

Authors:  O Dar; M R Salaman; M H Seifert; D A Isenberg
Journal:  Clin Exp Immunol       Date:  1988-09       Impact factor: 4.330

4.  Diminished response to an inhibitory signal in lymphocytes from patients with systemic lupus erythematosus.

Authors:  M Salata; J Golbus; B C Richardson
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

5.  The B-cell activation pathway in human systemic lupus erythematosus: imbalanced in vitro production of lymphokines and association with serum analytical findings.

Authors:  M L Gaspar; M Alvarez-Mon; C Gutierrez
Journal:  J Clin Immunol       Date:  1988-07       Impact factor: 8.317

6.  B-cell activation in HIV infection: relationship of spontaneous immunoglobulin secretion to various immunological parameters.

Authors:  H Mizuma; S Litwin; S Zolla-Pazner
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

7.  Studies of immune functions of patients with systemic lupus erythematosus. Complement-dependent immunoglobulin M anti-thymus-derived cell antibodies preferentially inactivate suppressor cells.

Authors:  T Sakane; A D Steinberg; J P Reeves; I Green
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

8.  Antibodies to polyadenylic acid in patients with myasthenia gravis.

Authors:  M Fischbach; J Lindstrom; N Talal
Journal:  Clin Exp Immunol       Date:  1981-01       Impact factor: 4.330

9.  Injection of mouse thyroglobulin and/or adult thymectomy do not break tolerance to thyroglobulin during the lupus like graft versus host disease in mice.

Authors:  F M van Rappard-van der Veen; Y M Kong; N R Rose; M Kimura; E Gleichmann
Journal:  Clin Exp Immunol       Date:  1984-03       Impact factor: 4.330

10.  Loss of suppressor T-lymphocyte function in patients with systemic lupus erythematosus (SLE).

Authors:  C Morimoto
Journal:  Clin Exp Immunol       Date:  1978-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.